German Cancer Research Center Joins Hands with Telix Pharmaceuticals to Develop Image-guided Prostate Surgery

Australia-based Telix Pharmaceuticals, a biopharmaceutical company in the clinical stage, which is focused on the development of therapeutic and diagnostic products based on targeted radiopharmaceuticals, has made an announcement stating that the company has entered into an agreement with the German Cancer Research Center – the Deutsches Krebsforschungszentrum (DKFZ) in Continue Reading